肿瘤诊断 | Oncology diagnostics
| Cellmid Limited | |
| Cellmid 有限公司是一家澳大利亚生物技术公司。公司针对多种病征——特别是实体瘤，研发具有创新性的、一流的诊断测试和治疗方法。 | Cellmid Limited is an Australian biotechnology company developing innovative first-in-class diagnostic tests and therapies for a number of disease indications, in particular solid tumours. |
| 更多信息 | More information |
| Clinical Genomics Technologies Pty Ltd | |
| Clinical Genomics公司利用突破性科学技术，开发新兴、具开创性、更便捷的方式以预防疾病、提高生活质量。Clinical Genomics成立于2006年并致力于开发新一代用于大肠癌诊断的产品。 | Clinical Genomics harness breakthrough science to create new, innovative and more accessible ways to prevent disease and enhance lives. Founded in 2006, Clinical Genomics develops next generation products for colorectal cancer diagnosis. |
| 更多信息 | More information |
| Imagion Biosystems | |
| Imagion Biosystems是一家澳大利亚上市公司，位在墨尔本和圣地亚哥。 公司专注于飞速崛起的纳米生物技术领域，重点从事癌症和其他人类疾病的早期发现工作。 | Imagion Biosystems is an Australian listed company based in Melbourne and San Diego. Our focus is in the rapidly emerging field of nanobiotechnology with an emphasis on the early detection of cancer and other human diseases. |
| 更多信息 | More information |
| Minomic International Ltd | |
| Minomic International Ltd (Minomic) 是澳洲一家私营生物标志发现公司，专门从事于前列腺癌的体外诊断 (IVD)、诊断成像和治疗 | Minomic International Ltd (Minomic) is an Australian privately owned biomarker discovery company specialising in in-vitro-diagnostics (IVD), diagnostic imaging and therapeutics for prostate cancer. |
| 更多信息 | More information |
| SpeeDx Pty Ltd | |
| SpeeDx致力于开发具有高经济效益的医用基因快速诊断技术。 | SpeeDx has been focused on the development of cost effective and rapid detection technologies for genetic-based medical diagnostics. |
| 更多信息 | More information |
| Sienna Cancer Diagnostics Ltd | |
| Sienna是一家位于澳大利亚墨尔本的生物科技公司。Sienna依托其在全球临床领域的庞大网络，推动了多种针对癌症的新式体外诊断产品(IVD)的研发。 | Sienna is a biotechnology company based in Melbourne, Australia. With the help of their large global clinical networks, Sienna is able to drive the discovery and development of novel IVD (in vitro diagnostic) tests for cancer. |
| 更多信息更多信息 | More information |